These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 20493713

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationships.
    Wu X, Wan Y, Mahalingam AK, Murugaiah AM, Plouffe B, Botros M, Karlén A, Hallberg M, Gallo-Payet N, Alterman M.
    J Med Chem; 2006 Nov 30; 49(24):7160-8. PubMed ID: 17125268
    [Abstract] [Full Text] [Related]

  • 3. Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring system.
    Murugaiah AM, Wallinder C, Mahalingam AK, Wu X, Wan Y, Plouffe B, Botros M, Karlén A, Hallberg M, Gallo-Payet N, Alterman M.
    Bioorg Med Chem; 2007 Nov 15; 15(22):7166-83. PubMed ID: 17825570
    [Abstract] [Full Text] [Related]

  • 4. From the first selective non-peptide AT(2) receptor agonist to structurally related antagonists.
    Murugaiah AM, Wu X, Wallinder C, Mahalingam AK, Wan Y, Sköld C, Botros M, Guimond MO, Joshi A, Nyberg F, Gallo-Payet N, Hallberg A, Alterman M.
    J Med Chem; 2012 Mar 08; 55(5):2265-78. PubMed ID: 22248302
    [Abstract] [Full Text] [Related]

  • 5. Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108-15 cells.
    Guimond MO, Wallinder C, Alterman M, Hallberg A, Gallo-Payet N.
    Eur J Pharmacol; 2013 Jan 15; 699(1-3):160-71. PubMed ID: 23211679
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.
    Wan Y, Wallinder C, Plouffe B, Beaudry H, Mahalingam AK, Wu X, Johansson B, Holm M, Botoros M, Karlén A, Pettersson A, Nyberg F, Fändriks L, Gallo-Payet N, Hallberg A, Alterman M.
    J Med Chem; 2004 Nov 18; 47(24):5995-6008. PubMed ID: 15537354
    [Abstract] [Full Text] [Related]

  • 7. Development of selective non-peptide angiotensin II type 2 receptor agonists.
    Alterman M.
    J Renin Angiotensin Aldosterone Syst; 2010 Mar 18; 11(1):57-66. PubMed ID: 19880657
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin Peptides as AT2 Receptor Agonists.
    Hallberg M, Sävmarker J, Hallberg A.
    Curr Protein Pept Sci; 2017 Mar 18; 18(8):809-818. PubMed ID: 28164758
    [Abstract] [Full Text] [Related]

  • 9. Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships.
    Wallinder C, Botros M, Rosenström U, Guimond MO, Beaudry H, Nyberg F, Gallo-Payet N, Hallberg A, Alterman M.
    Bioorg Med Chem; 2008 Jul 15; 16(14):6841-9. PubMed ID: 18599297
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Heterocyclic 1,7-disubstituted indole sulfonamides are potent and selective human EP3 receptor antagonists.
    Hategan G, Polozov AM, Zeller W, Cao H, Mishra RK, Kiselyov AS, Ramirez J, Halldorsdottir G, Andrésson T, Gurney ME, Singh J.
    Bioorg Med Chem Lett; 2009 Dec 01; 19(23):6797-800. PubMed ID: 19836233
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity.
    Georgsson J, Sköld C, Plouffe B, Lindeberg G, Botros M, Larhed M, Nyberg F, Gallo-Payet N, Gogoll A, Karlén A, Hallberg A.
    J Med Chem; 2005 Oct 20; 48(21):6620-31. PubMed ID: 16220978
    [Abstract] [Full Text] [Related]

  • 13. Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential.
    Unger T, Dahlöf B.
    J Renin Angiotensin Aldosterone Syst; 2010 Mar 20; 11(1):75-7. PubMed ID: 19861350
    [No Abstract] [Full Text] [Related]

  • 14. New insights into the SAR and binding modes of bis(hydroxyphenyl)thiophenes and -benzenes: influence of additional substituents on 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitory activity and selectivity.
    Bey E, Marchais-Oberwinkler S, Negri M, Kruchten P, Oster A, Klein T, Spadaro A, Werth R, Frotscher M, Birk B, Hartmann RW.
    J Med Chem; 2009 Nov 12; 52(21):6724-43. PubMed ID: 19831396
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Imidazole moiety replacements in the 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile.
    Velaparthi U, Liu P, Balasubramanian B, Carboni J, Attar R, Gottardis M, Li A, Greer A, Zoeckler M, Wittman MD, Vyas D.
    Bioorg Med Chem Lett; 2007 Jun 01; 17(11):3072-6. PubMed ID: 17398093
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.
    Pu J, Kreft AF, Aschmies SH, Atchison KP, Berkowitz J, Caggiano TJ, Chlenov M, Diamantidis G, Harrison BL, Hu Y, Huryn D, Steven Jacobsen J, Jin M, Lipinski K, Lu P, Martone RL, Morris K, Sonnenberg-Reines J, Riddell DR, Sabalski J, Sun SC, Wagner E, Wang Y, Xu Z, Zhou H, Resnick L.
    Bioorg Med Chem; 2009 Jul 01; 17(13):4708-17. PubMed ID: 19443228
    [Abstract] [Full Text] [Related]

  • 18. Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor.
    Georgsson J, Sköld C, Botros M, Lindeberg G, Nyberg F, Karlén A, Hallberg A, Larhed M.
    J Med Chem; 2007 Apr 05; 50(7):1711-5. PubMed ID: 17358051
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.